CADILA TO MARKET ANTI-CANCER DRUG

A A

Cadila Pharmaceuticals Ltd on Monday said it would market anti cancer drugs GCS (Granulocyte Colony Stimulating) factor and GMCS (Granulocyte Macrophage Colony Stumating) Factor by 2006 end. "The animal trials are being conducted presently and the complete standardization process would be completed by next year end when we plan to enter the market," P K Ghosh, president, Cadila Pharmaceuticals Ltd -Biocare SBU told the agency on the sidelines of a biotechnology seminar here.

The Economic Times (http://economictimes.indiatimes.com/articleshow/1294828.cms)